share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

诺瓦瓦克斯医药 | 4:持股变动声明-董事 YOUNG JAMES F
美股sec公告 ·  06/21 16:28
Moomoo AI 已提取核心信息
On June 18, 2024, James F. Young, associated with Novavax Inc [NVAX], completed the sale of 7,500 shares of common stock in two separate transactions. The first transaction involved the sale of 6,393 shares at a price of $13.62 per share, while the second saw 1,107 shares sold at $14.28 each. Following these transactions, Young holds a total of 69,260 Novavax shares. The total market value of the disposed shares amounted to $102,880.62. These sales were executed as open market or private sales and are part of Young's direct holdings.
On June 18, 2024, James F. Young, associated with Novavax Inc [NVAX], completed the sale of 7,500 shares of common stock in two separate transactions. The first transaction involved the sale of 6,393 shares at a price of $13.62 per share, while the second saw 1,107 shares sold at $14.28 each. Following these transactions, Young holds a total of 69,260 Novavax shares. The total market value of the disposed shares amounted to $102,880.62. These sales were executed as open market or private sales and are part of Young's direct holdings.
2024年6月18日,诺瓦瓦克斯医药公司[NVAX]的相关人士詹姆斯·F·扬在两笔分别交易中售出了7500股普通股。 第一笔交易涉及价格为每股13.62美元的6393股的出售,而第二笔交易为每股14.28美元的1107股。 在这些交易之后,扬持有共69260股诺瓦瓦克斯医药公司的股份。 被处理的股票的总市值为102880.62美元。 这些销售是在公开市场或私下销售中进行的,并且是扬的直接持股的一部分。
2024年6月18日,诺瓦瓦克斯医药公司[NVAX]的相关人士詹姆斯·F·扬在两笔分别交易中售出了7500股普通股。 第一笔交易涉及价格为每股13.62美元的6393股的出售,而第二笔交易为每股14.28美元的1107股。 在这些交易之后,扬持有共69260股诺瓦瓦克斯医药公司的股份。 被处理的股票的总市值为102880.62美元。 这些销售是在公开市场或私下销售中进行的,并且是扬的直接持股的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息